Functional Implications of DNA Methylation in Adipose Biology.

Abstract

The twin epidemics of obesity and type 2 diabetes (T2D) are a serious health, social, and economic issue. The dysregulation of adipose tissue biology is central to the development of these two metabolic disorders, as adipose tissue plays a pivotal role in regulating whole-body metabolism and energy homeostasis (1). Accumulating evidence indicates that multiple aspects of adipose biology are regulated, in part, by epigenetic mechanisms. The precise and comprehensive understanding of the epigenetic control of adipose tissue biology is crucial to identifying novel therapeutic interventions that target epigenetic issues. Here, we review the recent findings on DNA methylation events and machinery in regulating the developmental processes and metabolic function of adipocytes. We highlight the following points: <i>1</i>) DNA methylation is a key epigenetic regulator of adipose development and gene regulation, <i>2</i>) emerging evidence suggests that DNA methylation is involved in the transgenerational passage of obesity and other metabolic disorders, <i>3</i>) DNA methylation is involved in regulating the altered transcriptional landscape of dysfunctional adipose tissue, <i>4</i>) genome-wide studies reveal specific DNA methylation events that associate with obesity and T2D, and <i>5</i>) the enzymatic effectors of DNA methylation have physiological functions in adipose development and metabolic function.